
Work Here?
Machinify uses artificial intelligence to optimize decision-making in healthcare. It provides AI-driven applications that improve operational efficiency for health plans, payers, and providers, acting as a central nervous system to manage data-driven decisions. Its products streamline processes like claims processing and utilization management by deploying a growing portfolio of applications on the Machinify platform, designed for fast implementation and immediate ROI. Differences from competitors include an AI-first platform tailored to healthcare administration, a rapid deployment model, and a customer-focused approach that aims to deliver tangible results quickly. The company’s goal is to transform healthcare administration by reclaiming control over healthcare expenditures and improving efficiency and patient outcomes through data-driven decisions.
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
501-1,000
Company Stage
Series A
Total Funding
$15.6M
Headquarters
Palo Alto, California
Founded
2016
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$15.6M
Below
Industry Average
Funded Over
3 Rounds
Industry standards
Medical, dental, & vision
Flexible work environment
Generous PTO
Competitive salary
Equity
401(k)
Sponsorship
Generous L&D Reimbursement policy
Machinify adds genetic testing expertise to its comprehensive payment intelligence platform. Machinify announced a new genetic testing capability, extending the platform's intelligence into one of healthcare's fastest-growing and most clinically complex specialties. The expansion represents another step in applying Machinify's AI to increasingly sophisticated healthcare payment decisions, helping health plans address areas that have outpaced traditional payment integrity approaches. Genetic testing represents one of the fastest-growing and most clinically nuanced areas of healthcare, with more than 150,000 tests on the market today and more than 10 new ones introduced daily. The pace of innovation, combined with evolving evidence, coding structures, payer policies, and coverage requirements, makes the category particularly difficult to manage at scale. The capability builds on Machinify's acquisition of InformedDNA's genetic testing payment integrity business, encoding decades of specialized genetic testing review expertise directly into the Machinify platform. By combining AI with deep clinical expertise, Machinify enables health plans to make more informed decisions throughout the payment lifecycle, whether preventing incorrect payments before they occur or identifying overpayments downstream. "Precision medicine is generating more clinical complexity than any human review organization can keep up with, and genetic testing is the sharp edge of that," said David Pierre, CEO of Machinify. "We didn't build a genetic testing tool. We taught our AI to reason about genetic testing the same way it already reasons about the rest of the claim, with deep human expertise built in. That's the whole idea behind Machinify: as healthcare gets more complex, machine intelligence keeps the lead because every decision makes the next one smarter. That's how we bend the cost curve." The platform applies a specialized genetic testing knowledge base alongside each payer's medical policies to evaluate claims within their full clinical and contractual context. Grounded in Machinify's experience supporting Medicare, Medicaid, and commercial health plans, the models are developed, validated, and continuously governed by the company's board-certified geneticists and clinical experts. Every determination is transparent, defensible, and fully auditable. The approach is already delivering measurable results. In one Medicaid program, the capability identified more than $70 million in savings across reproductive and pharmacogenomic testing while improving the accuracy of payments for these services going forward. "Specialty areas like genetic testing are more important than ever; the science is evolving daily, and the spend has accelerated dramatically," said Tom Magnotta, President of Complex Payment Solutions at Machinify. "We are actively investing in and expanding our content on the platform. Genetic testing is just one of many areas where Machinify is deploying solutions to solve complex challenges for our clients using an AI-first approach." The genetic testing solution is available now to Machinify clients through the platform's real-time pre-payment solution or as a post-payment extension where retrospective recovery is required.
Machinify has launched a genetic testing capability on its payment intelligence platform for health plans. The expansion follows the company's acquisition of InformedDNA's genetic testing payment integrity business. The new capability uses AI combined with clinical expertise to help health plans manage payment decisions for genetic testing, one of healthcare's fastest-growing areas with over 150,000 tests currently on the market and more than 10 new ones introduced daily. The platform applies a specialised knowledge base alongside payer medical policies to evaluate claims. In one Medicaid programme, the capability identified over $70 million in savings across reproductive and pharmacogenomic testing. Machinify's platform is deployed by over 85 health plans, including many of the top 20, representing more than 270 million lives.
Dallas-Based Machinify closes $670M acquisition of nasdaq-listed Performant Healthcare. Machinify said that bringing together Performant's deep audit and recovery expertise with Machinify's advanced AI platform will enable the company to deliver faster, more accurate insights, further reduce administrative burden, and unlock greater savings for health plans. Left: Machinify CEO David Pierre; Right: Simeon Kohl, CEO of Performant Healthcare [Photos: LinkedIn/Performant] Dallas-based healthcare intelligence company Machinify has closed its acquisition of Plantation, Florida-based Performant Healthcare (Nasdaq: PHLT) for roughly $670 million. Machinify said the deal expands its AI-powered platform to reach a broader range of clients, including government programs, and accelerates its mission to simplify and modernize healthcare payments. With the acquisition, the New Mountain Capital-backed company closed its second major acquisition in 2025 to expand its AI-powered operating system to a broader range of clients. "We're thrilled to bring Performant into Machinify with such highly complementary assets," Machinify CEO David Pierre said in a statement. "Performant has built deep relationships in the government sector, which expands on Machinify's strong and expanding presence with national and regional payers. Together, we can offer our clients the most complete, data-driven platform for ensuring every healthcare dollar is used effectively." Machinify said that combining Performant's deep audit and recovery expertise with Machinify's advanced AI platform will enable the company to deliver faster, more accurate insights, further reduce administrative burden, and unlock greater savings for health plans. The integration enhances Machinify's ability to serve commercial and government payers with end-to-end intelligence, Machinify added, spanning claim error detection, prevention, recovery, and coordination of benefits. 'Supporting better outcomes' Performant CEO Simeon Kohl will remain with the company, joining the Machinify leadership team. Kohl said the acquisition comes at a key time in the industry. "I'm excited to join forces with Machinify at such a pivotal moment for the industry," Kohl said. "By combining our deep expertise with Machinify's AI platform, we'll be able to deliver even greater value to our clients - streamlining the payment process, improving accuracy, and supporting better outcomes across the healthcare system." "Performant strengthens Machinify's leadership as the next-generation platform for payment accuracy and intelligence," Matt Holt, managing director and president of private equity at New Mountain Capital, said in a statement. "This strategic integration aligns with Machinify's mission to make payments smarter, faster, and more transparent. We're excited about the significant value it will unlock for payers, providers, and the entire healthcare ecosystem." With the addition of Performant, Machinify said it now supports hundreds of millions of claims annually and delivers billions in savings through its unified AI and human-expertise model - helping clients reduce waste, improve provider relationships, and ensure accuracy from contracts to claims. Performant's shares will no longer be publicly traded and will be delisted from Nasdaq, as the company will now operate as a privately held entity. New York-based New Mountain Capital emphasizes business building and growth, rather than excessive risk, as it pursues long-term capital appreciation. The firm currently manages private equity, strategic equity, credit, and net lease real estate funds with more than $55 billion in assets under management. Track Dallas-Fort Worth's business and innovation landscape with its curated news in your inbox Tuesday-Thursday. R E A D N E X T. * AI Tinkerers Now Has a Dallas-Fort Worth Chapter: 'This Is for People Who Are Actually Using AI' Data scientist Anmolika Singh put Dallas on the global AI Tinkerers map. At the first meetup, more than 30 pros - founders to Fortune 500 technologists - showed up to trade ideas, projects, and solutions. * UT Dallas Study Tests AI as a Triage Tool in Breast Cancer Screenings Rather than replace radiologists, UTD researchers say AI could help flag low-risk mammograms for automated review. The approach could cut costs and ease delays as cancer rates rise and the diagnostic workforce shrinks. * With $4M Pre-Seed Funding, North Texas' Humancore Launches 'Multiplayer AI Advisor' Platform Plano-based Humancore describes its Multiplayer platform as an AI advisor that goes beyond traditional coaching and generic prompts by understanding not just the manager, but also their team. * Is Your Organization Ready for AI? Key Considerations to Assess AI Readiness Avoid common pitfalls with practical insights from guiding Fortune 500 companies through AI adoption * Caring for Its Elders, Intelligently: How Technology Can Bring Ease, Connection, and Better Health to Aging Americans Dallas is aging faster than ever, with seniors facing rising challenges of isolation, health, and care. Technology, when designed with empathy, can bridge these gaps - connecting families, empowering caregivers, and enabling prevention. By building tools with empathy, Dallas Next LLC can transform elder care from survival to peace of mind and joy.
Performant Healthcare, Inc. (Nasdaq: PHLT) (the “Company” or “Performant”), a leading provider of technology-enabled payment integrity, eligibility, and rela...
New Mountain Capital has agreed to acquire Machinify, a Palo Alto, California-based provider of artificial intelligence-powered software focused on healthcare payments.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
501-1,000
Company Stage
Series A
Total Funding
$15.6M
Headquarters
Palo Alto, California
Founded
2016
Find jobs on Simplify and start your career today